In a groundbreaking move within the fields of laboratory supply and biotech research, Maxanim proudly announces its integration into the esteemed Gentaur Group. This partnership marks a significant milestone in the pursuit of providing cutting-edge testing tools, reagents, and specialized solutions for laboratories across the USA and Europe. With a focus on delivering high-quality products tailored for research and diagnostic purposes, Maxanim's inclusion within the Gentaur Group fortifies its commitment to excellence and innovation in the field.

Maxanim's expertise lies in the provision of laboratory reagents and tools essential for a wide array of scientific endeavors, ranging from fundamental research to advanced diagnostic applications. As part of the Gentaur Group, Maxanim extends its reach and capabilities, ensuring a broader access to its comprehensive portfolio of products and services.

One of the flagship offerings by Maxanim is its extensive range of ELISA kits meticulously designed for research purposes. These kits, renowned for their reliability and accuracy, empower researchers with the tools necessary to explore various biological pathways, identify biomarkers, and unravel the mysteries of diseases. Whether unraveling the complexities of cancer biology or deciphering the mechanisms of infectious diseases, Maxanim's ELISA kits, Panbio serve as invaluable assets in the scientific community's quest for knowledge and breakthroughs.

The expanded portfolio of Maxanim now includes a comprehensive range of products such as Abbott, ABM Labs' innovative tools for gene expression studies, Adeno and AAV vectors for gene therapy applications, iPSC reagents for stem cell research, Lentivectors and Retroviral vector for gene delivery systems, as well as Adenovirus vectors for vaccine development and gene transfer experiments. Additionally, Maxanim offers products from renowned suppliers such as Cusabio, Nova Lifetech plasmids, Gentarget, SBI, ABMGood, and Genprice, ensuring access to a diverse array of high-quality reagents and tools.

Furthermore, Maxanim takes pride in its prowess in manufacturing custom recombinant proteins and plasmids, catering to the specific needs and requirements of researchers and laboratories. With a keen emphasis on quality assurance and precision, Maxanim ensures that each custom product meets the highest standards of excellence, empowering scientists with the flexibility to embark on ambitious projects and push the boundaries of scientific discovery.

In addition to recombinant proteins and plasmids, Maxanim specializes in the design and production of primers, rabbit plyclonal antibodies, and mouse monoclonal antibodies. These essential tools play a pivotal role in various experimental techniques, including PCR, Western blotting, and immunohistochemistry, facilitating the detection and analysis of specific molecules with unparalleled specificity and sensitivity.

The integration of Maxanim into the Gentaur Group not only amplifies its product offerings but also reinforces its commitment to customer satisfaction and service excellence. With a dedicated team of experts and scientists, Maxanim remains steadfast in its mission to empower researchers and laboratories with the tools and resources necessary to drive groundbreaking discoveries and advancements in the realms of biotechnology and medical research.

Moreover, Maxanim's collaboration with Gentaur Group enhances its distribution network, ensuring prompt and efficient delivery of products to laboratories across the USA and Europe. Through strategic partnerships and alliances, Maxanim endeavors to streamline the procurement process for researchers, enabling them to focus their efforts and resources on their scientific pursuits.

With Maxanim's integration into the Gentaur Group, researchers can now benefit from a seamless procurement experience, accessing a wide range of products including ELISA kits, PCR reagents, Antybody, and quality controls like NatTtrol. Whether it's basic research, drug discovery, or clinical diagnostics, Maxanim remains committed to providing the necessary tools and support to accelerate scientific progress and improve human health worldwide.